Navigation Links
Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
Date:5/7/2009

the pulmonary safety of AZ-004. The Company observed that AZ-004, administered twice within a 24-hour period, was safe and generally well tolerated in the study. There were no systematic differences in post-dose pulmonary function between AZ-004 and placebo, and no respiratory adverse events. In April 2009, Alexza initiated a thorough QTc study in healthy subjects and a smoker/non-smoker pharmacokinetic study in healthy subjects. The Company expects to initiate the remaining two studies during the current quarter and projects that all of the clinical work for the NDA will be completed by the end of the third quarter of 2009.

- AZ-104 (Staccato loxapine). Alexza is developing AZ-104 to treat patients suffering from acute migraine headaches. AZ-104 is a lower dose version of AZ-004. In January 2009, Alexza initiated an AZ-104 outpatient, multi-center, randomized, double-blind, single-dose, placebo-controlled study intended to enroll 360 patients who have migraines, with or without aura. Two dose levels of AZ-104 are being evaluated in the clinical trial, 1.25 mg and 2.5 mg. The primary efficacy endpoint for the trial is headache pain relief at 2 hours post-dose, using the standard IHS 4-point rating scale. Secondary efficacy endpoints for the trial include pain relief and other symptom assessments at various time points. Safety evaluations will also be made throughout the clinical trial period. Alexza projects that data from the Phase 2b study will be announced by the end of the third quarter of 2009

AZ-004 and AZ-104 have been licensed to Symphony Allegro, and the Company has the right to repurchase all rights to these product candidates.

Conference Call Information

Alexza will host a conference call today, May 7, 2009, at 5:30 p.m. Eastern Time. A replay of the call will be available for two weeks following the event. The conference call, replay and webcast are open to all
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
2. Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches
3. Alexzas AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
4. Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
5. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
6. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
7. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
8. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
9. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
10. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
11. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... Mass. , June 18, 2013 ... the company was named Overall Performance Leader in Imaging ... Equipment & Infrastructure report. Philips also received Best in ... its imaging products: Ingenuity Core 128 Computed Tomography ... ultrasound and PageWriter TC70 cardiograph. The annual Best in ...
(Date:6/18/2013)... 18, 2013 Unilife Corporation ("Unilife" or "Company") ... and manufacturer of injectable drug delivery systems, today announced ... www.unilife.com . The new site includes additional products, videos, ... on a regular basis. Mr. Alan ... emerging global leader for injectable drug delivery systems, we ...
Breaking Medicine Technology:Three-in-One X3130 Appliance Inlet Module 2Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2Unilife Launches New Corporate Website 2
... Inc. (Nasdaq: MSHL ), an oncology company ... cancer metabolism, announced today that it has filed a ... Exchange Commission for a rights offering to existing stockholders ... stock. The Company will announce further details regarding the ...
... Feb. 21, 2012  Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... will present a company overview at Citi,s 2012 Global Health ... ET at the Waldorf Astoria in New York City. ... available on the "Investors & Media" section of the Company,s ...
Cached Medicine Technology:Marshall Edwards Announces Rights Offering to Stockholders 2Marshall Edwards Announces Rights Offering to Stockholders 3
(Date:6/19/2013)... June 19, 2013 Imprivata ®, ... today announced that Imprivata OneSign ® leads the ... Mid-Term Performance Review: Software & Services report . CIOs ... Imprivata on the superior performance of its products and ... they indicate that Imprivata is integral to their long-term ...
(Date:6/19/2013)... Kona, HI (PRWEB) June 19, 2013 ... coordination company is dedicated to being an effective and ... wedding, reception needs. They have partnered up with Tom ... advice and discounts on most of Hawaii’s activities. , ... shows how clients can get the lowest prices on ...
(Date:6/19/2013)... The producers of Viewpoints TV are pleased ... city is located in the center of what is called ... image and become an affordable city to live, work, raise ... the United States with a workforce strong in the high ... cost-of-living, friendly business environment and more than 100 days of ...
(Date:6/19/2013)... School of Nursing researcher has received a four-year, $1.49 ... mood in women with diabetes who are depressed. , ... can reduce blood pressure and affect how well women ... Institute of Nursing Research at the National Institutes of ... and colleagues hypothesize that women receiving vitamin D will ...
(Date:6/19/2013)... Chicago is cracking down on bed bugs. New ... will require landlords to exterminate any and all reported bed ... ordinance also makes tenants responsible for reporting signs of bed ... often include disposing of furniture, bedding, and more. , In ... did more bed bug business in Chicago than any other ...
Breaking Medicine News(10 mins):Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2Health News:Viewpoints TV Announces June Air Dates for Phoenix, AZ 2Health News:Loyola receives $1.5 million grant to study vitamin D for diabetes and depression 2Health News:Chicago Ordinance Requires Landlords and Tenants to Take Responsibility for Bed Bugs 2
... enough to guarantee complete parity in treatment, expert says ... guidelines from the American Heart Association have been able ... heart attack patients, a new study finds. , Called ... in care can be eliminated while at the same ...
... may sound simple, but not so in the formation of ... implications, Mitchell A. Lazar, M.D., Ph.D., director of the Institute ... School of Medicine, and colleagues report in the current issue ... intermediate state between early-stage fat cells and fully mature ones ...
... ... ... 17, 2010 -- Centegra Health System and Dell Services ( www.dell.com ) ... region’s first-ever Health Information Exchange (HIE). The program also provides local physicians with access ...
... that may prove to be a more effective treatment for ... Press in the May issue of the journal Cancer ... notoriously intractable leukemia stem cells that often escape standard treatment ... myelogenous leukemia (CML) is a deadly form of leukemia that ...
... available in French . , Montreal, May ... links between cell phone use and brain tumours is ... the Interphone International Study Group. Jack Siemiatycki, a professor ... the University of Montreal Hospital Research Center, says restricted ...
... for tests that predict the illness, researchers say , MONDAY, ... disease in middle age may have genetic roots, even if ... illnesses in their background, a new study has found. , ... to screen for genetic predispositions to serious lung disease before ...
Cached Medicine News:Health News:Heart Attack Guidelines Close Racial Gaps in Hospital Care 2Health News:Heart Attack Guidelines Close Racial Gaps in Hospital Care 3Health News:A fat cell grows up 2Health News:A fat cell grows up 3Health News:Centegra Health System Launches New Physician Network 2Health News:Centegra Health System Launches New Physician Network 3Health News:Combination therapy targets stubborn leukemia stem cells 2Health News:World's biggest study on cell phones and brain cancer inconclusive 2Health News:Lung Disease Can Be Genetic Even Without Family History 2
... Paradigm II utilizes powerful ... modules that provide complete flexibility for you to ... Quality system, while providing transparent accountability to all ... or Intranet . Paradigm II uses ...
... is the power behind each MasterControl ... the essential building blocks to construct ... to boost operational efficiency, improve product ... and quality standards. Click here to ...
... automated, easy to operate and maintain. The ... by flexible snap-seal pockets which minimize the ... of the water. Offered in two-, four-, ... accommodate bags of various sizes. ThermoLine Thawing ...
... Our thawing systems are automated, easy to ... from the outside environment by flexible snap-seal ... bacterial or viral contamination of the water. ... the systems can also accommodate bags of ...
Medicine Products: